Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hinge Health, Inc. Class A ( (HNGE) ) has shared an update.
On August 5, 2025, Hinge Health announced its financial results for the second quarter of 2025, reporting a 55% year-over-year revenue increase to $139.1 million. Despite a GAAP loss from operations of $580.7 million, the company achieved a non-GAAP income from operations of $26.1 million, reflecting strong market acceptance of its AI-powered platform. The company also reported a 32% increase in clients and provided optimistic revenue guidance for the third quarter and full year 2025, indicating continued growth and strategic momentum in the healthcare industry.
The most recent analyst rating on (HNGE) stock is a Buy with a $43.00 price target. To see the full list of analyst forecasts on Hinge Health, Inc. Class A stock, see the HNGE Stock Forecast page.
Spark’s Take on HNGE Stock
According to Spark, TipRanks’ AI Analyst, HNGE is a Neutral.
Hinge Health, Inc. is showing strong financial performance with robust revenue growth and effective cost management. Technical indicators suggest positive short-term momentum, and the valuation appears reasonable. However, ongoing profitability challenges and the lack of dividend yield are concerns.
To see Spark’s full report on HNGE stock, click here.
More about Hinge Health, Inc. Class A
Hinge Health is a company focused on automating healthcare delivery, particularly for musculoskeletal conditions. Utilizing an AI-powered care model, wearable devices, and expert clinicians, the company provides personalized, evidence-based care aimed at improving patient outcomes and reducing costs for clients. Hinge Health is headquartered in San Francisco, California.
Average Trading Volume: 1,045,592
Current Market Cap: $3.51B
For an in-depth examination of HNGE stock, go to TipRanks’ Overview page.